Clinical implications of Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: A study of 69 patients at 2 University Hospitals

Scandinavian Journal of Infectious Diseases

Volumn 32, Issue 6, 2000, Pages 651-656

  Tsiodras, S ^a   Pittet, D ^a   Carmeli, Y ^a   Eliopoulos, G ^a   Boucher, H ^a   Harbarth, S ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AZTREONAM; CEFEPIME; CEFOTETAN; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MEZLOCILLIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; TIMENTIN; TOBRAMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; AUTOPSY; BACTERIUM ISOLATE; CATHETER; COMORBIDITY; DEATH; DISEASE SEVERITY; DRUG EXPOSURE; FEMALE; GRAM NEGATIVE INFECTION; HEALTH CARE SYSTEM; HOSPITAL CARE; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT CARE; PNEUMONIA; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; SCORING SYSTEM; SEPSIS; SEPTICEMIA; SOFT TISSUE INFECTION; STENOTROPHOMONAS MALTOPHILIA; SURGERY; UNIVERSITY HOSPITAL;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOSPITALS; HUMANS; INTUBATION; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MORBIDITY; RETROSPECTIVE STUDIES; STENOTROPHOMONAS MALTOPHILIA; SURVIVAL RATE; TRIMETHOPRIM RESISTANCE; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0034525349     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655400459577     Document Type: Article

References (34)

1. Antimicrobial-drug resistance
2. Emergence of vancomycin resistance in Staphylococcus aureus
3. Pseudomonas maltophilia infections in man
4. Clinical problems posed by multiresistant nonfermenting gram-negative pathogens
5. Nosocomial infections due to Xanthomonas maltophilia (Pseudomonas maltophilia) in patients with cancer
6. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia
7. Comparison of various in vitro susceptibility methods for testing Stenotrophomonas maltophilia
8. Mucocutaneous and soft tissue infections caused by Xanthomonas maltophilia. A new spectrum
9. Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: A prospective, multicenter study of 91 episodes
10. Stenotrophomonas (Xanthomonas) maltophilia: A multidrug-resistant nosocomial pathogen
11. Gram-negative bacteremia I. Etiology and ecology
12. CDC definitions for nosocomial infections
13. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
14. Impact of immunomodulating therapy on morbidity in patients with severe sepsis
15. Use of antimicrobial drugs in general hospitals. I. Description of population and definition of methods
16. Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis
17. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus
18. Nonfermentative gram-negative bacilli of nosocomial interest
19. Infections caused by Pseudomonas maltophilia with emphasis on bacteremia: Case reports and a review of the literature
20. Septicemia due to Xanthomonas species and non-aeruginosa Pseudomonas species: Increasing incidence of catheter-related infections
21. Xanthomonas maltophilia bacteremia in immunocompromised hematological patients
22. Molecular epidemiology of Xanthomonas maltophilia colonization and infection in the hospital environment
23. Comparison of treatment with imipenem vs. ceftazidime as a predisposing factor for nosocomial acquisition of Stenotrophomonas maltophilia: A historical cohort study
24. A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: Implications for therapy
25. Distribution in clinical material and identification of Pseudomonas maltophilia
26. Predisposing factors and antibiotic use in nosocomial infections caused by Xanthomonas maltophilia
27. Associated mortality and clinical characteristics of nosocomial Pseudomonas maltophilia in a university hospital
28. Risk factors for epidemic Xanthomonas maltophilia infection/colonization in intensive care unit patients
29. Resistant nosocomial gram-negative bacillary pathogens: Acinetobacter baumannii, Xanthomonas maltophilia, and Pseudomonas cepacia
30. Xanthomonas maltophilia bacteremia: An analysis of 32 cases
31. Stenotrophomonas (Xanthomonas) maltophilia urinary tract infection. A disease that is usually severe and complicated
32. Stenotrophomonas maltophilia meningitis. Report of two cases and review of the literature
33. Assessment and management of foot disease in patients with diabetes